|
CYTSA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.11669562485872E-11 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.865840E-01 |
| Stage1-vs-Stage3 |
4.146600E-01 |
| Stage1-vs-Stage4 |
5.193800E-04 |
| Stage2-vs-Stage3 |
8.731600E-02 |
| Stage2-vs-Stage4 |
1.301160E-03 |
| Stage3-vs-Stage4 |
1.745730E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.70769998142362E-09 |
| Normal-vs-Asian |
5.44009282066327E-15 |
| Caucasian-vs-AfricanAmerican |
5.163600E-01 |
| Caucasian-vs-Asian |
7.105200E-01 |
| AfricanAmerican-vs-Asian |
7.523000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.803200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
6.41120000000051E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.604600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.116000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.320400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.336400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.137200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.540400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.312050E-02 |
| Classical-VS-Follicular |
8.630600E-01 |
| Classical-VS-Other |
1.075190E-01 |
| Classical-VS-Normal |
1.62525548574877E-12 |
| Tall-VS-Follicular |
3.496000E-02 |
| Tall-VS-Other |
5.115200E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
1.777030E-01 |
| Follicular-VS-Normal |
1.62447832963153E-12 |
| Other-VS-Normal |
1.55250000000162E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.318020E-03 |
|
|
